BBY
46
10
HAS
33
3
CL
58
2
NVDA
56
-4
UA
50
-9
NAVI
52
5
CPB
30
6
MRK
25
-2
LNC
39
3
SIG
52
3
LB
63
22
WAT
55
2
ROST
63
12
CFG
70
6
KMB
39
2
BK
74
2
AXP
71
2
SWK
64
5
FITB
63
3
BSX
67
-3
BBY
46
10
HAS
33
3
CL
58
2
NVDA
56
-4
UA
50
-9
NAVI
52
5
CPB
30
6
MRK
25
-2
LNC
39
3
SIG
52
3
LB
63
22
WAT
55
2
ROST
63
12
CFG
70
6
KMB
39
2
BK
74
2
AXP
71
2
SWK
64
5
FITB
63
3
BSX
67
-3
Financhill
Back

Vir Biotechnology Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31

VIR
Vir Biotechnology

Last Price:
7.12
Seasonality Move:
40.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Vir Biotechnology Price Quote

$7.12

Vir Biotechnology Key Stats

Sell
31
Vir Biotechnology (VIR) is a Sell
Day range:
$6.88 - $7.27
52-week range:
$6.56 - $13.09
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
15.57
P/B ratio:
0.79%
Volume:
891.7K
Avg. volume:
1.3M
1-year change:
-27.64%
Market cap:
$980.6M
Revenue:
$39.5M
EPS:
$-3.92

How Much Does Vir Biotechnology Make?

Is Vir Biotechnology Growing As A Company?

Data Unavailable

Vir Biotechnology Stock Price Performance

  • Did Vir Biotechnology Stock Go Up Last Month?
    Vir Biotechnology share price went down by -6.44% last month
  • Did VIR's Share Price Rise Over The Last Year?
    VIR share price fell by -27.64% over the past 1 year

What Is Vir Biotechnology 52-Week High & Low?

Vir Biotechnology Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Vir Biotechnology?

  • How Much Debt Does Vir Biotechnology Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Vir Biotechnology Have?
    Cash and short term investments quarterly total is $914.5M
  • What Is Vir Biotechnology’s Book Value Per Share?
    Book value per share is 9.08

Is Vir Biotechnology Cash Flow Positive?

  • What Is VIR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$466.6M
  • What Is Vir Biotechnology’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $4.8M
  • What Is Vir Biotechnology’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $253.8M

Vir Biotechnology Return On Invested Capital

  • Is Management Doing A Good Job?
    VIR return on invested capital is -35.62%
  • What Is Vir Biotechnology Return On Assets?
    ROA measures how assets are converting to revenues and is -29.88%
  • What Is VIR Return On Equity?
    ROE is a measure of profitability and is -35.62%

Vir Biotechnology Earnings Date & Stock Price

Vir Biotechnology Competitors

Vir Biotechnology Dividend Yield

Vir Biotechnology Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -43.97%
Revenue: 0% -56.81%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 29.50
Upside from Last Price: 314.33%

Major Shareholders

  • How many VIR shares are owned by institutional investors?
    134.5M VIR shares are owned by institutional investors
  • How many VIR shares are owned by insiders?
    5.5M VIR shares are owned by insiders